# OnCo record paper-widmark-lancet (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-widmark-lancet/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-widmark-lancet" ;
  schema:name "Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial"@en ;
  schema:description "Paper cited by one trial page, indexed on Europe PMC as PubMed record 31227373 and published in The Lancet; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-widmark-lancet/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s0140-6736(19)31131-6>, <https://pubmed.ncbi.nlm.nih.gov/31227373/>, <https://europepmc.org/article/MED/31227373> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s0140-6736(19)31131-6> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Widmark A, Gunnlaugsson A, Beckman L, et al." ;
  onco:trials <https://onco.cc/trials/hypo-rt-pc/> ;
  onco:journals <https://onco.cc/journals/lancet/> .